Bipolar Depression Management with Lithium and Alternative Therapies

Rationale for Maintaining Lithium Therapy

Lithium is the gold standard treatment for bipolar disorder and the only FDA-approved agent for bipolar disorder in adolescents age 12 and older 1
Lithium shows superior evidence for prevention of both manic and depressive episodes in long-term maintenance therapy 1
Withdrawal of maintenance lithium therapy is associated with an increased risk of relapse, especially within the 6-month period following discontinuation 2, 1
Studies show that >90% of adolescents who were non-compliant with lithium treatment relapsed 2, 1

For bipolar depression, the American Academy of Child and Adolescent Psychiatry recommends olanzapine-fluoxetine combination as a first-line option, not risperidone 1

Olanzapine-fluoxetine combination has shown efficacy for bipolar depression 1
Lurasidone has demonstrated efficacy for bipolar depression and is ranked second for response after olanzapine-fluoxetine combination 1
Lamotrigine may be considered for maintenance therapy, particularly for preventing depressive episodes 1

Develop a monitoring plan for the discontinuation trial, as patients with mood disorders may experience a return of symptoms weeks to months after their last dose 3
Taper lithium slowly to avoid withdrawal symptoms or rebound worsening of symptoms 3
Ensure that an effective alternative medication regimen is established before completing the lithium taper 3, 1
Educate the patient about early signs and symptoms of mood episodes so that resumption of therapy can be initiated if necessary 2